Casimiroin

Overview

Casimiroin is a QR2 and Aromatase inhibitor, with an IC 50 of 54.1 μM against QR2 and an IC 50 of 3.92 μM against aromatase. Casimiroin exhibits antimutagenic activity and inhibits DMBA ( HY-W011845 )-induced mutations in Salmonella typhimurium . Casimiroin suppresses DMBA -induced precancerous lesions in mouse mammary organ cultures. Casimiroin can be used in breast cancer-related research.

Application

Products | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Salmonella Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Bacterial Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Quinone Reductase | Products > Signaling Pathways > Cytochrome P450 | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-N11855
• CAS No.: 477-89-4
• Molecular Formula: C12H11NO4
• Molecular Weight: 233.22
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source